Drug Type Small molecule drug |
Synonyms Flurazepam Monohydrochloride, Flurazepam dihydrochloride, Flurazepam hydrochloride (USP) + [4] |
Target |
Action agonists |
Mechanism GABAA receptor agonists(Gamma-aminobutyric acid A receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (07 Apr 1970), |
Regulation- |
Molecular FormulaC21H23ClFN3O |
InChIKeySAADBVWGJQAEFS-UHFFFAOYSA-N |
CAS Registry17617-23-1 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D00695 | Flurazepam Hydrochloride |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Anesthesia | Japan | 25 Apr 1975 | |
| Sleep Initiation and Maintenance Disorders | Japan | 25 Apr 1975 |





